Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellent post. I feel exactly the same, although you said it better. We can debate addresses and glitches all day long, but the bottom line is that we are anchored in this zone until we are found by new investors. With doctors signing up, training commencing, EMEA waking up, FemCelz starting, AmnioStem and StemSpine in the wings, that day could happen any time. I could go on and on but will safe ya the reading ;)
Or the note holders who mostly have bleed out clauses. Also indicated by the OS slowly increasing
I know MA, no worries. CELZ strong!
CELZ 10-k.
Gross Revenue:
12/31/17 $4,800
12/31/18 $124,400
GROSS REVENUE UP 2,492%
Gross Profit:
12/31/17 ($3,200)
12/31/18 $54,025
GROSS PROFIT UP 1,788%
Beginning cash on hand: $13,697
Ending cash on hand: $304,056
Accumulate what you can and BUCKLE UP 5/15
CELZ 10-k.
Gross Revenue:
12/31/17 $4,800
12/31/18 $124,400
GROSS REVENUE UP 2,492%
Gross Profit:
12/31/17 ($3,200)
12/31/18 $54,025
GROSS PROFIT UP 1,788%
Beginning cash on hand: $13,697
Ending cash on hand: $304,056
Accumulate what you can and BUCKLE UP 5/15
CELZ 10-k.
Gross Revenue:
12/31/17 $4,800
12/31/18 $124,400
GROSS REVENUE UP 2,492%
Gross Profit:
12/31/17 ($3,200)
12/31/18 $54,025
GROSS PROFIT UP 1,788%
Beginning cash on hand: $13,697
Ending cash on hand: $304,056
Accumulate what you can and BUCKLE UP 5/15
As we have discussed, and the filing shows, CELZ COULD drift up to 1.2B or so OS, so that increase is no shocker.
What we don’t know I show fast it will be gobbled up, or if the shares will event be converted or paid off.....
Tons happening that can change it all to the good!!!!
Gross Revenue:
12/31/17 $4,800
12/31/18 $124,400
GROSS REVENUE UP 2,492%
Gross Profit:
12/31/17 ($3,200)
12/31/18 $54,025
GROSS PROFIT UP 1,788%
Beginning cash on hand: $13,697
Ending cash on hand: $304,056
Accumulate what you can and BUCKLE UP 5/15
There is still a lot going on behind the scenes with CELZ. We will rock this summer, maybe even starting today, and keep on rolling to 2025 and beyond.
The ONLY thing that will stop that, is if some giant comes along and makes an offer CELZ cannot refuse.
Like noted in the filing, there are 14 locations in 5 regions. How long before other doctors catch the wave and that doubles, then doubles again?
And to think, we are trading at .01...... What a joke.
Even our harshest critic could only pic on little issues that mean nothing.
CELZ is cash flowing, and flowing faster every day. $CELZ 2019!!!!
100% agree
I agree 100%. It’s a huge sleeper. Those of us that got in early just have to wait until the masses find it. The math is crazy and .01 is an absolute no brainer IMO
Looking back at the shareholder update and seeing that they hired trainers tells you that doctors are starting to notice and are being scheduled. That will only ramp up. Same for EMEA where they hired marketing folks for Europe. Ya have to ask yourself why?
Exactly CP. getting in or averaging down at .01 will be short lived. I am hearing folks are liking this filing, knowing what it was. Seeing the doctors opening and treatments expanding is waking up many. We will see much more revenue in 6 weeks. How much will it run between now on then is the question.
Vanilla Ice tonight. A one hit wonder. $CELZ
Good catch.
Well said Win. My feelings exactly. We are in the right stock at the right time.
Even that is not a guarantee... ;)
No worries. Many many longs are lurking, being patient!!
We will see the due 10-K today. Just a word of advice to all longs here... this is NOT the major filing we should be hoping changes the tide.
The chart and TA may/will move us up in the days and weeks to follow but this 10-K isn't likely to be the thrust unless there is some juicy detail not yet revealed.
What it should do is shed some light on the remaining toxic May 14th 2018 note - fingers crossed it's all wrapped up, and then even more curious will be what we learn about the conversions our three new "institutional" investors have done.
We will also see the revenue from Q4.
It will continue to show forward progress :)
I am far more excited about the 2019 Q1 that will have revs from the doctors that started this year. That will be the filing that really kicks this into gear. Then we will see better revs each Q following as more doctors and procedures start generating revenue.
I think the PPS could and should start moving as the development of the company is getting clearer and clearer and be able to buy/add around .01 is just silly. I hope to keep adding before the run.
Yessir, it’s due today. I would guess AH.
Okie Dokie
Hahahaha. I thought you were one of our regulars at first glance. Let’s start a new month with excitement. CELZ has done a lot in 2019 already by signing several new doctors and getting FemCelz off the ground. New trainers for the demand and new marketing folks in EMEA due to interest. Great times are ahead.
Q after Q is what you will see for the foreseeable future. CaverStem rolling along adding doctors, FemCelz just starting revs, followed by StemSpine then AmnioStem. And just think, you can buy in or average down at about .01. Ridiculous low IMO
We will see the due 10-K tomorrow. Just a word of advice to all longs here... this is NOT the major filing we should be hoping changes the tide.
The chart and TA may/will move us up in the days and weeks to follow but this 10-K isn't likely to be the thrust unless there is some juicy detail not yet revealed.
What it should do is shed some light on the remaining toxic May 14th 2018 note - fingers crossed it's all wrapped up, and then even more curious will be what we learn about the conversions our three new "institutional" investors have done.
It will continue to show forward progress :)
CaverStem™ domestic activities: As previously reported, we are continuing marketing to physicians across the United States. Since our last shareholder update several physicians have joined CaverStem™ ........... physicians in Hawaii, California, Ohio, Texas and Tennessee........ These physicians came to us through our physician marketing program as previously disclosed. We are continuing to use this marketing tool with mailers and emails with follow up personal or telephone communication with physicians across the country.
.......we have added additional medical personnel to travel to each physicians office to train.
Ditto. +100.
Excited to see CELZ add new doctors and some trainers to speed up the process.
Excited to see CELZ add some marketing folks added to Europe.
Excited to see a second stream of potential patients and revenue from FemCelz.
Really excited to see them working on TV ads. That will be huge IMO.
Thats wasssup ;)
I wouldn’t doubt they have been working on it for a while. They all go back to Medistem;)
Thanks hann-d. It will be interesting to see what the next step is,.... CaverStem 3.0. We have already had a few hints. It’s comforting to see how brilliant Ichim and team are, and how dedicated our participating docirs are are! Very bright future ahead. IMO.
I went back and looked. Been a QB since 2016. I only caught one late filing and it just a few days late. Other than the board noise, it doesn’t matter to me. I really think we are golden. Everything is falling into place. We just need the right spark.
Since the last shareholder update we gained 5 doctors and added FemCelz. If they all get the word out, maybe we see 10 more next update. We know Dr Elias is fielding calls and having WebEx meetings with dozens of interest doctors (Well, the longs do. There no proof for the others).
When this does wake up, it’s will run hard IMO. .07 last summer was just a dress rehearsal :)
Gmoney... I am confident that they will file on time. They have been a QB filer for a few years now and were only three days late on one filing that I remember.
Good question Wolf. I am not the resident expert as to when Dr. Gershman started using CaverStem. I believe 2017.
I am saying NEW as in a new treatment now being commercialized for patients through the participating doctors office. We know a few doctors started in late 2018 and several more have been added in 2019, as referenced in the last few shareholder updates. That’s new for the average patient.
FemCelz is just starting NEW as I type. The first patients were treated last week I believe.
And CELZ hopes to have StemSpine as a NEW treatment later in the year.
Lots of NEWness going around :)
What we are watching develop here is a company that has BIG potential that is in its INFANCY right now.
Just like when you go to the dentist and see the brochures for the different teeth whitening options, or different ways to improve your smile, or when you go to any doctor’s office and see the brochures for different meds or corrective procedures, CELZ is setting up a portfolio of PATENTED and marketed stem cell procedures.
What you will see spread through Urologist offices across the country will be brochures for CaverStem. Your options will be OTC options, prescription options, surgical procedures or CaverStem. Some folks will pop the pills, some will opt for CaverStem, some may need surgery. Pretty simple if you ask me.
CaverStem is a NEW and SAFE treatment, that depending on many factors, could be one and done…..permanent. It is just the first out of the gate for CELZ. None of the risks associated with meds or surgery.
The same wave will be happening at OBGYN offices all across the country where woman will have the FemCelz option.
In the not too distant future those going to the back doctor will have the StemSpine treatment as an option.
It will just keep picking up steam as CELZ will keep rolling out and improving their patented procedures and could become a HUGE player in the medical world.
Since the last shareholder update in February, things picked up speed already IMHO. CELZ added 5 new doctors and others are inquiring, they added trainers to aid in the demand, and new marketing in Europe who is also showing interest.
It’s an incredible opportunity to buy in low at .01 IMHO
It would be awesome. Hopefully they will, and I bet they do once this picks up speed. With Gershman’s connections, I am excited to see the TV commercials. Maybe it will surprise us.
I guess I kinda see what you are saying about the overall training. I think we opined about it before. If they send out 2500 emails a month and even get 1% interest that is a lot of vetting and training. Once those doctors talk to their buddies, training new doctors COULD be an issue real fast. I am glad they added trainers and tweaked things.
I am sure the issues in Russia and complicated. I have no idea what to expect there and I suspect Russia might be a dead issue, who knows?
I did find it encouraging that they hired Bianchi. That shows me there is or will be bigger interest throughout EMEA. That was a small surprise for me.
I was surprised they added doctors in Cali, TX, TN and OH. I did not know that was happening.
Wow, two choices, one or the other, and you think CELZ insiders are dumping shares through the MM’s? That’s where you and I (longs) have a huge disconnect. I cannot think of ANY reason why CELZ insiders would be selling. They must be as anxious to see the stock move back up as anyone. They are businessmen, doctors and scientists and don’t need to dump shares for cash. Zero reason why the insiders would be selling.
And where would big pharma get all these shares to dump to keep the PPS down? Do I think big pharma has a dog in the fight. You bet I do. They could be working a few angles here. I would be shocked if they weren’t.
I think, and I could be wrong, you are missing the obvious answers. Right in the many filings, in black and white, CELZ openly disclosed that they issued several notes and warrants to pay for all that they doing to commercialize their business. Each are convertible after a time period.
One note is horrible. Way too many shares and way to little cash. It was flat out ugly.
The newer notes are better, have leak out clauses etc. but are still notes and warrants none the less. Anyone can do the math that if ALL were converted the OS could reach 1.2B or so. It’s not bizarre behavior at all.
It is my belief that the note holders are the most likely cause of the selling. Proof of that is that the OS goes up each month. I believe, and CELZ seems to know, that those notes will end soon enough and be offset by revenue making then self sufficient.
The other place we have a huge disconnect is that I can point out 10 things gleaned out of PR’s and or doctors offices that are up and running and even advertising and you will say some things just cannot be verified and are suspect, then jump to CELZ is clearly borderline illegitimate because they refuse to address the trading.
Why so extreme? Why cannot you admit they have done a ton of things, have so much going on and are very legitimate. Why is it all suspect just because the PPS blows. If we stayed at .05 would you be happy and say CELZ is legit?
I think it is crystal clear that on most days there are more notes clearing than there is buying. We need new blood. New eyes. Tons of folks are watching. Waiting for that right day. Will it be when the 10k is out? Nit likely. Will it be when Q1 comes out, or bigger news in between. Probably.
When the spark is lit and this runs, will you say it’s legitimate?
I will play along for a minute. I can even give and example if needed, but what exactly would you have CELZ do about the MM’s?
Updated...... This is what the INVESTORS KNOW about CMTH.......but don't trust me or anyone on the blog. Do you own DD please, and you too will KNOW......
The FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem ONLY uses your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore, FDA does not object to these procedures.
CaverStem has been shown to be effective even in patients who do not respond to PDE5 inhibitors. CaverStem is safe.
Several doctors in the US have been vetted and signed and are now OPEN and treating patients (Doctors Gershman, Said, Bieri, Liu, Narayan, Niemczyk and Sanderson). Currently you can make an appointment any of those locations along with Dr. Antonini in Rome, Italy.
CELZ added physicians in Hawaii (Sanderson), California, Ohio, Texas and Tennessee (to be named soon). CELZ will continually add the new physicians to the CaverStem™ website as they come aboard.
To speed up new physician training, CELZ added additional medical personnel to travel to each physicians office to train.
Due to the increased international demand and to compliment the existing relationship with Scott Shea, Thomas Bianchi has joined the company as the international sales representative.
Over 50 domain names have been registered showing that MANY more doctors are being vetted or have shown interest. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria.
CaverStem has begun a series of mailer and email campaigns introducing the CaverStem procedure to licensed physicians in the areas of urology, sexual function and plastic surgery. This campaign which will be expanded on a monthly basis with follow up mailers and emails and calls from our sales representatives. It's the goal to reach out to a minimum of 2500 new physicians each month by these methods. CaverStem reported good replies from the January emails.
CaverStem has also increased its online presence on Social Media and by placing banner advertising on websites and search engines attracting the active male. They are currently scripting a television commercial which will be edited to direct patients to each physician in their area.
U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients with excellent results, however Government exemptions are required for the ongoing import of our device in Russia. This is a slow and tedious process in getting approval, therefore our progress has been delayed.
Your DD will show that Dr. Gershman has been performing the procedure with EXCELLENT results…Up to 90% success rate, even in difficult patients. CELZ has received positive feedback from treating physicians of a 70% to 90% efficacy in their patients. Obviously results differ depending on the age and health of the patient and cause and severity of their erectile dysfunction.
A one-year trial has concluded and will PROVE the same results and you can watch it here; https://clinicaltrials.gov/ct2/show/NCT03699943?recrs=deghi&fund=2&lupd_s=09%2F27%2F2018&lupd_d=14 Please review this. CELZ is working on their paper for publication. This is ongoing and in compliance with contractual obligations. Once the paper has been approved by The Journal of Translational Medicine and a publication date advised, shareholders will be updated. Additionally, CELZ has designed an electronic patient registry that is intended to include data from the clinical trial, data from treating physicians using centrifuge technology with a 30cc to 60cc bone marrow aspiration and the second generation, needle only.
Revenue has now started, CMTH is cash flowing. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and increasing each month. CMTH anticipates reaching financial self-sufficiency by revenues from sales in 2019.
CMTH has Institutional Investors now, slowing dilution and providing much better terms as CMTH completes the commercialization phase. The most recent notes that were issued in 2018 were renegotiated providing cash for operations.
CaverStem signed with PatientGain to redesigning the website for the anticipated HUGE volume of traffic CaverStem will generate. This has generated many calls to the vetted doctors.
CMTH has started commercializing and scheduling patients for the FemCelz procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Many of the existing CaverStem affiliated physician's will also treat female patients for sexual function and we anticipate that they will be the leaders in progressing the FemCelz program.
CMTH anticipates acquiring the Virility Centers of America brand from affiliate company Creative Medical Health, Inc. The use of the Virility Centers brand is related to male and female wellness clinics, including sexual function (CaverStemTM and FemCelzTM), incontinence and infertility. This brand will compliment the CaverStem and FemCelz brands.
CaverStem and FemCelz are just TWO of SEVERAL patents held by CMTH. 4 NEW patents were applied for in 2018.
Gershman and Ichim and team have already successfully commercialized Medistem.
CaverStem, FemCelz, StemSpine & AmnioStem have all be TRADEMARKED
We KNOW CaverStem + FemCelz + StemSpine + AmnioStem = NASDAQ
PLEASE read the sticky posts seen when logging in to iHub through a browser!!
IYO, why would it rumble tomorrow when you just posted that there was noting of substance.........
Even though this alone is substantial.....”We have added physicians in Hawaii, California, Ohio, Texas and Tennessee. We will continually add the new physicians to the CaverStem(TM) website, begin the patient awareness campaign in each area and schedule physician training”
You want to call everything silence, and useless, but want it to run..... I am so confused.